A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice.

With PUUC alone, there was also an increase in the percentage of IFN‐γ enriched monofunctional CD4 + T RM (Figure 3P ), although this increase did not reach statistical significance.

also in 111,027 other papers